Cargando…
Effect of Long-Term Allopurinol Therapy on Left Ventricular Mass Index in Patients with Ischemic Heart Disease; A Cross-Sectional Study
BACKGROUND: Left ventricular hypertrophy (LVH), as assessed by measurement of left ventricular mass (LVM), is one of the most important cardiovascular risk factors. It is commonly present in patients with ischemic heart disease (IHD), irrespective of the level of blood pressure; recently, oxidative...
Autores principales: | Alem, Manal M, Aldosari, Sarah R, Alkahmous, Alhassna A, Obad, Adam S, Fagir, Nagy M, Al-Ghamdi, Bandar S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6903809/ https://www.ncbi.nlm.nih.gov/pubmed/31827327 http://dx.doi.org/10.2147/VHRM.S226009 |
Ejemplares similares
-
A Randomized, Controlled Trial of the Effect of Allopurinol on Left Ventricular Mass Index in Hemodialysis Patients
por: Rutherford, Elaine, et al.
Publicado: (2020) -
Inter-relationships between left ventricular mass, geometry and arterial stiffness
por: Alem, Manal M., et al.
Publicado: (2020) -
Allopurinol and endothelial function: A systematic review with meta‐analysis of randomized controlled trials
por: Alem, Manal M.
Publicado: (2018) -
Allopurinol treatment adversely impacts left ventricular mass regression in patients with well-controlled hypertension
por: Gingles, Christopher R., et al.
Publicado: (2019) -
Increased left ventricular mass index is present in patients with type 2 diabetes without ischemic heart disease
por: Seferovic, Jelena P., et al.
Publicado: (2018)